179Indexed trials
Market Rank #22 · Evidence Tier A
Taiwan
Neuroscience Intelligence
Taiwan neuroscience intelligence: 179 indexed trials, 13 institutions, research score 33.33.
42Recruiting
13Research institutions
33.3Research score
Evidence profile
65Sponsors
22Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 33 · ML priority 33 · Confidence 85 · Evidence 33.3
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
parkinsons36trials
autism23trials
alzheimers21trials
adhd20trials
epilepsy9trials
other_neurology8trials
schizophrenia8trials
stroke8trials
depression6trials
pain_neuropathy4trials
Leading indexed sponsors
National Taiwan University Hospital42trials
Merck Sharp & Dohme LLC15trials
Chang Gung Memorial Hospital13trials
China Medical University Hospital9trials
Hoffmann-La Roche6trials
Pfizer5trials
Eli Lilly and Company4trials
Novartis Pharmaceuticals4trials
Taipei Medical University4trials
Mackay Memorial Hospital3trials